Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.65 USD | -1.29% | -5.79% | +52.39% |
Financials (USD)
Sales 2024 * | 108M | Sales 2025 * | 277M | Capitalization | 5.29B |
---|---|---|---|---|---|
Net income 2024 * | -437M | Net income 2025 * | -307M | EV / Sales 2024 * | 49.1 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 19.1 x |
P/E ratio 2024 * |
-9.11
x | P/E ratio 2025 * |
-15.1
x | Employees | 628 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 22.2% |
Latest transcript on ImmunityBio, Inc.
1 day | -1.29% | ||
1 week | -5.79% | ||
Current month | -4.26% | ||
1 month | +55.80% | ||
3 months | +57.73% | ||
6 months | +84.78% | ||
Current year | +52.39% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Adcock
CEO | Chief Executive Officer | 55 | 20-09-30 |
Founder | 71 | 14-11-30 | |
David Sachs
DFI | Director of Finance/CFO | 46 | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 71 | 14-11-30 | |
Cheryl L. Cohen
BRD | Director/Board Member | 58 | 19-05-31 |
Wesley Clark
BRD | Director/Board Member | 78 | 21-02-23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.02% | 2 M€ | -.--% | ||
0.02% | 1,487 M€ | +9.17% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 7.65 | -1.29% | 4,923,091 |
24-05-16 | 7.75 | -4.32% | 4,874,075 |
24-05-15 | 8.1 | -3.57% | 4,694,768 |
24-05-14 | 8.4 | -2.67% | 6,866,991 |
24-05-13 | 8.63 | +6.28% | 6,184,298 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.39% | 5.29B | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- IBRX Stock